Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-12-23
2000-05-16
Owens, Amelia
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514454, 549264, A61K 3135
Patent
active
060638095
ABSTRACT:
Safe, effective first-pass inhibiting compounds and citrus-derived substances are provided. Formulations containing the compounds are also provided as are methods for inhibiting the first pass effect.
REFERENCES:
patent: 1840798 (1932-01-01), Tressler
patent: 3071474 (1963-01-01), Gross
patent: 3300320 (1967-01-01), Distelkamp et al.
patent: 3917865 (1975-11-01), Shaw et al.
patent: 4497838 (1985-02-01), Bonnell
patent: 4562087 (1985-12-01), Kryger
patent: 4569853 (1986-02-01), Strobel
patent: 5061502 (1991-10-01), Cully et al.
patent: 5229116 (1993-07-01), Edgar et al.
patent: 5362714 (1994-11-01), Radford et al.
patent: 5478723 (1995-12-01), Parkinson et al.
patent: 5567592 (1996-10-01), Benet et al.
J. Owusu-Yaw, et al., "Alcohol Deterpenation of Orange Oil", J. Food Science, 1986, vol. 51, No. 5, pp. 1180-1182.
J.J. Neal, et al., "Inhibition of Insect Cytochromes P450 by Furanocoumarins", 1994, Pesticide Biochemistry and Physiology 50, pp. 43-50.
Motoharu Ju-ichi, et al., "The Structures of Claudimerines-A and -B, Novel Bicoumarins from Citrus hassaku.sup.1) ", Chem. Pharm. Bull., Jan. 1996, vol. 44, No. 1 pp. 11-14.
Yuko Takemura, et al., "Structure of Furobinordentatin, A Novel Bicoumarin From Citrus Yuko", Chem. Pharm. Bull. vol. 42, pp. 997-998, Apr. 1994.
Yuko Takemura, et al., "Structures of Furobinordentatin and Furobiclausarin, Two Novel Bicoumarins from Citrus Plants.sup.1) ", Chem. Pharm. Bull. vol. 42, No. 12, pp. 2436-2440, Dec. 1994.
Yuko Takemura, et al., "Three New Bicoumarins from Citrus hassaku.sup.1) ", Chem. Pharm. Bul. vol. 42, No. 6, pp. 1213-1215, Jun. 1994.
Chihiro Ito, et al., "Structure of Bisosthenon, a Novel Dimeric Coumarin from Citrus Plants.sup.1) ", Chem. Pharm. Bull., Aug. 1990, vol. 38, No. 8, pp. 2102-2107.
Chihiro Ito, et al., "Isolation of New Constituents from Citrus Plants", Chem. Pharm. Bull., Sep. 1990, vol. 38, No. 9, pp. 2586-2588.
Chihiro Ito, et al., "Structure of Bisosthenon A Novel Dimeric Coumarin From Citrus Plants.sup.1) ", Chem. Pharm. Bull., 1989, vol. 37, No. 7, pp. 1957-1959.
Yuko Takemura, et al., "Citbismine-A, A New Bisacridone Alkaloid from Citrus Paradisi", Chem. Pharm. Bull., Jul. 1994, vol. 42, No. 7, pp. 1548-1549.
Yuko Takemura, et al., "Three New Acridone-Coumarin Dimers From a Citrus Plant.sup.1 ", Heterocycles, 1994, vol. 38, No. 8, pp. 1937-1941.
Chihiro Ito, et al., "A New Biscoumarin from Citrus Plants", Chem. Pharm. Bull., Sep. 1993, vol. 41, No. 9, pp. 1657-1658.
R.D.H. Murray, "Coumarins", Natural Product Reports, 1989, vol. 6, pp. 477-505.
Sudam C. Basa, "Natural Bicoumarins", Phytochemistry, Nov. 9, 1987, vol. 27, No. 7, pp. 1933-1941.
P.R. Ashurst, et al., Food Flavorings Second Edition, 1995, 3pp.
R.D.H. Murray, Chemistry Department, University of Glasgow, "Naturally Occurring Plant Coumarins", 1991, pp. 283-316.
Gary C. Yee, "Effect of Grapefruit Juice on Blood Cyclosporin Concentration", The Lancet, Apr. 15, 1995, vol. 345, pp. 955-956.
Sigusch et al, "Influence of Grapefruit Juice on the Pharmakokinetics of a Slow Release Nifedipine Formulation", Pharmazie 49, 1994, pp. 522-524.
Chihiro Ito, et al., "New Binary Coumarins from Citrus Plants", Chem. Pharm. Bull. vol. 38, No. 5, pp. 1230-1232, 1990.
Yuko Takemura, et al., "Structural Elucidation of Citrumarins: Four Novel Binary Coumarins Isolated from Citrus Plants", Chem. Pharm. Bull. vol. 41, No. 1, pp. 73-76, 1993.
Chihiro Ito, et al., Structure of Hassmarin, a Novel Biscoumarin from a Citrus Plant.sup.1), Chem. Pharm. Bull., Jul. 1993, vol. 41, No. 7, pp. 1302-1304.
Uwe Fuhr, et al., "Inhibitory effect of grapefruit juice and its bitter principal, naringenin, on CYP1A2 dependent metabolism of caffeine in man*", Br. J. Clin. Pharmacol., Department of Clinical Pharmacology, University Hospital Frankfurt/Main, Germany, vol. 35, 1993, pp 431-436.
F. Peter Guengerich, et al., "In vitro inhibition of dihydropyridine oxidation and aflatoxin B.sub.1 activation in human liver microsomes by naringennin and other flavonoids", Carcinogenesis, vol. 11, No. 12, pp. 2275-2279, 1990.
David G. Bailey, et al., "Grapefruit Juice and Drugs", Clin. Pharmacokinet, vol. 26, No. 2, pp. 91-98, 1994.
David J. Edwards, et al., "Identification of 6',7'-Dihydroxybergamottin, a Cytochrome P450 Inhibitor, In Grapefruit Juice", Drug Metabolisms and Disposition, vol. 24, No. 12, pp. 1287-1290, 1996.
Barbara Ameer, et al., "Drug Interactions with Grapefruit Juice", Clin. Pharmacokinet, vol. 33, No. 2, pp. 103-121, Aug. 1997.
Katsuyuki Fukuda, et al., "Grapefruit Component Interacting with Rat and Human P450 CYP3A: Possible Involvement of Non-Flavenoid Components in Drug Interaction", Biol. Pharm. Bull., vol. 20, No. 5, pp. 560-564, May 1997.
Frank H. Bellevue, et al., "Synthesis and Biological Evaluation of 6',7'-Dihydroxybergamottin (6,7-DHB), A Naturally Occurring Inhibitor of Cytochrome P450 3A4", Biorganic & Medicinal Chemistry Letter, vol. 7, No. 20, pp. 2593-2598, 1997.
David J. Edwards, et al., "Naringin and Naringenin are not the Primary CYP3 A Inhibitors in Grapefruit Juice", Life Sciences, vol. 59, No. 13, pp. 1025-1030, 1996.
M. Bourian, et al., "Coumarin Derivatives in Grapefruit Juice and Their Interactions with Mammalian Drug Metabolising Enzyme Systems", Annual Congress on Medicinal Plant Research, vol. 44, pp. 43, 1996.
William K. Chan, et al., "Mechanism-Based Inactivation of Human Cytochrome P450 3A4 by Grapepfruit Juice and Red Wine", Life Sciences, vol. 62, No. 10, pp. PL 135-142, 1998.
Kan He, et al., "Inactivation of Cytochrome P450 3A4 by Bergamottin, a Component of Grapefruit Juice", Chem. Res. Toxicol, vol. 11, pp. 252-259, 1998.
M.T. Obermeier, et al., "Effects of bioflavonoids on hepatic P450 activities", Xeonbiotica, vol. 25, No. 6, pp. 575-584, 1995.
Marina Tinel, et al., "Inactivation of Human Liver Cytochrome P-450 by the Drug Methoxsalen and Other Psoralen Derivatives", Biochemical Pharmacology, vol. 36, No. 6, pp. 951-955, 1987.
R. Chayen, et al., "Interaction of citrus juices with felodipine and nifedipine", The Lancet, vol. 337, Apr. 6, 1991.
Phyllissa Schmiedlin-Ren, et al., "Mechanisms of Enhanced Oral Availability of CYP3A4 Substrates by Grapefruit Constituents", Drug Metabolism and Disposition, vol. 25, No. 11, pp. 1228-1233, 1997.
Katsuyuki Fukada, et al., "Specific CYP3A inhibitors in grapefruit juice: furocoumarin dimers as components of drug interaction", Pharmacogenetics, vol. 7, pp. 391-396, 1997.
Barbara Ameer, et al., "Flavanone absorption after naringin, hesperiden, and citrus administration", Clinical Pharmacology & Therapeutics, vol. 60, No. 1, pp. 34-40, Jul. 1996.
J. Rashid, et al., "Quercetin, an in vitro inhibitor of CYP3A, does not contribute to the interaction between nifedipine and grapefruit juice", Br J clin Pharmac, vol. 36, pp. 460-463, 1993.
David G. Bailey, et al., "Grapefruit juice-felodipine interaction: Mechanism, predictability, and effect of naringin", Clinical Pharmacology & Therapeutics, vol. 53, No. 6, pp. 637-642, Jun. 1993.
David G. Bailey, et al., "Effect of grapefruit juice and naringin on nisoldipine pharmacokinetics", Clinical Pharmacology & Therapeutics, vol. 54, No. 6, pp. 589-594, Dec. 1993.
Uwe Fuhr, MD, et al., "The fate of naringin in humans: A key to grapefruit juice-drug interactions?", Clinical Pharmacology & Therapeutics, vol. 58, No. 4, pp. 365-373, Oct. 1995.
W.A. Ritschel, et al., "Pilot study on bioavailability of coumarin and 7-hydroxycoumarin upon peroral administration of coumarin in a sustained-release dosage form", Journal of Clinical Pharmacology, vol. 21, No. 7, pp. 294-300, Jul. 1981.
O.H. Hishmat, et al., "Synthesis of furodiketochroman and bisfurocoumarin derivatives and their biological activity", Arch. Pharmacal Res. vol. 11, No. 2, pp. 87-92, 1988.
Derek E. Wright, "The Orthosomycins, A New Family Of Antibiotics", Tetra, vol. 35, No. 10, pp. 1207-1237, 1979.
Ashkit K. Ganguly, et al., "Determination Of The Absolute Sterochemistry At the C16 Orthoester Of Enverninomicin Antibiotics; A Novel Acid-Catalyzed Isomerization Of Orthoesters", Tetrahedron Letters, vol. 38, No. 46, pp
Bioavailability Systems, LLC
Owens Amelia
LandOfFree
Anti-first-pass effect compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anti-first-pass effect compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-first-pass effect compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-259295